Clinical Trial Update: Single Dose Radiotherapy (SDRT) With or Without Adjuvant Systemic Therapy for Oligometastatic Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating single dose radiotherapy with or without adjuvant systemic therapy for oligometastatic prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Adenocarcinoma
• Prostate Cancer

Snippet

Sponsor: Fundacao Champalimaud | Conditions: Metastatic Prostate Cancer, Prostate Adenocarcinoma | Phase 2 | Status: UNKNOWN